USPTO serial 79271037
DENK INGREDIENTS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 20, 2020
- Examiner
- SABLE, ERIC
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with DENK INGREDIENTS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,446*
Plus Government fees of $1,700
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
DE
DE
DE
DE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Keith A. Weltsch
Keith A. Weltsch Scully, Scott, Murphy & Presser, P.C.400 Garden City PlazaSuite 300Garden City, 11530Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals used in industry, science, agriculture, horticulture and forestry except fungicides, herbicides, insecticides and parasiticides, in particular for use in the food, dietary supplement, pharmaceutical and cosmetics industries, including in the form of precursors and intermediates, and being additives and auxiliaries; artificial sweeteners | ACTIVE | — |
| 003 | Plant extracts and vegetable oils for cosmetic purposes, including in the form of precursors and intermediates, and being additives and auxiliaries, namely, plant extracts and vegetable oils sold as components of cosmetics | ACTIVE | — |
| 005 | chemicals for pharmaceutical and medical purposes sold as the components of pharmaceutical preparations for the treatment of diseases and/or conditions of alimentary tract and metabolism, blood and blood forming organs, cardiovascular system, genito-urinary system and sex hormones, antiinfectives for systemic use, musculo-skeletal system, nervous system and respiratory system, disturbances with and support of digestive enzymes, for optimizing the supply of nutrients to mother and child, for the promotion of fertility, for the relief and elimination of lactose intolerance, for the development of teeth, bones and muscles growth, for care during pregnancy and breastfeeding, for supporting the memory, concentration and learning, for the care of the immune system, for the strengthening and maintenance of joints, cartilage, bones and muscles, for the magnesium supply of heart, nerves and muscles, for increasing the iron requirement, for increasing the sperm formation and for the folic acid care before and during pregnancy; animal and vegetable oils and plant extracts for pharmaceutical and medical purposes sold as components of pharmaceutical preparations for the treatment of diseases and/or conditions of alimentary tract and metabolism, blood and blood forming organs, cardiovascular system, genito-urinary system and sex hormones, antiinfectives for systemic use, musculo-skeletal system, nervous system and respiratory system, disturbances with and support of digestive enzymes, for optimizing the supply of nutrients to mother and child, for the promotion of fertility, for the relief and elimination of lactose intolerance, for the development of teeth, bones and muscles growth, for care during pregnancy and breastfeeding, for supporting the memory, concentration and learning, for the care of the immune system, for the strengthening and maintenance of joints, cartilage, bones and muscles, for the magnesium supply of heart, nerves and muscles, for increasing the iron requirement, for increasing the sperm formation and for the folic acid care before and during pregnancy; protein supplements for pharmaceutical and medical purposes; nutritional supplements for pharmaceutical and medical purposes; all the aforesaid goods being in the form of precursors and intermediates, and being additives and auxiliaries | ACTIVE | — |
| 035 | Wholesale and retail store services featuring pharmaceutical and chemical preparations used in industry, science, agriculture, horticulture and forestry, especially for use in the foodstuff, food supplement, pharmaceutical and cosmetics industries, artificial sweeteners, pains and diets, plant extracts and plant oils for cosmetic purposes, chemical preparations for pharmaceutical and medical purposes, animal oils and plant oils as well as plant extracts for pharmaceutical and medical purposes, proteins for pharmaceutical and medical purposes, food supplements for pharmaceutical and medical purposes, minerals and vitamins | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Denk Ingredients GmbH
- Other trademarks owned by DENK PHARMA GmbH & Co. KG
- Other trademarks owned by DENK PHARMA GmbH & Co. KG
- Other trademarks owned by DENK PHARMA GmbH & Co. KG
- Other trademarks in Class 001
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 035
- Similar marks named DENK INGREDIENTS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 18, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 20, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jun 10, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 10, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 7, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 6, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 6, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 20, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 20, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 4, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 4, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 31, 2020 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jul 15, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 15, 2020 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jul 15, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 30, 2020 | ALIE | ASSIGNED TO LIE | — |
| Jun 29, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 25, 2020 | DCPN | CHANGE OF OWNER RECEIVED FROM IB | — |
| Jun 16, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 15, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 15, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 13, 2020 | ATRV | ATTORNEY REVIEW COMPLETED | — |
| Jan 10, 2020 | CREV | CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED | — |
| Jan 4, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 27, 2019 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Dec 13, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 13, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 20, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 19, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 16, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 12, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 12, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 2, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |